immune checkpoint

You have access
Immune Check Point CD40–CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma Cells
REGINA M. HILLEBRAND, ANNABELLE VOGT, CHRISTIAN P. STRASSBURG, MARIA A. GONZALEZ-CARMONA and INGO G.H. SCHMIDT-WOLF

Anticancer Research September 2019, 39 (9) 4643-4652; DOI: https://doi.org/10.21873/anticanres.13645
You have access
PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma
YASUNAO KOGASHIWA, MASANORI YASUDA, HIROYUKI SAKURAI, MITSUHIKO NAKAHIRA, YOSHIE SANO, KENJI GONDA, TETSUYA IKEDA, HITOSHI INOUE, KIYOMI KUBA, SUSUMU OBA, JUNICHI ISHIKAWA, YUICHIRO ENOKI, SATOKO MATSUMURA, KAZUHIKO MINAMI, YASUHIRO EBIHARA and MASASHI SUGASAWA

Anticancer Research March 2017, 37 (3) 1417-1424;
You have access
Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a Mouse Model of Subcutaneous Tumor
YOSHITARO SHINDO, KIYOSHI YOSHIMURA, ATSUO KURAMASU, YUSAKU WATANABE, HIDEAKI ITO, TOMOKO KONDO, ATSUNORI OGA, HIROSHI ITO, SHIGEFUMI YOSHINO, SHOICHI HAZAMA, KOJI TAMADA, HIDEO YAGITA and MASAAKI OKA

Anticancer Research January 2015, 35 (1) 129-136;

Main menu